- Home
- ATYR vs NODK Comparison
ATYR vs NODK Comparison
Compare ATYR & NODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- NODK
- Stock Information
- Founded
- ATYR 2005
- NODK 1946
- Country
- ATYR United States
- NODK United States
- Employees
- ATYR N/A
- NODK N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- NODK Property-Casualty Insurers
- Sector
- ATYR Health Care
- NODK Finance
- Exchange
- ATYR Nasdaq
- NODK Nasdaq
- Market Cap
- ATYR 306.2M
- NODK 261.8M
- IPO Year
- ATYR 2015
- NODK 2017
- Fundamental
- Price
- ATYR $5.13
- NODK $13.00
- Analyst Decision
- ATYR Strong Buy
- NODK
- Analyst Count
- ATYR 6
- NODK 0
- Target Price
- ATYR $20.20
- NODK N/A
- AVG Volume (30 Days)
- ATYR 3.6M
- NODK 21.2K
- Earning Date
- ATYR 08-12-2025
- NODK 08-07-2025
- Dividend Yield
- ATYR N/A
- NODK N/A
- EPS Growth
- ATYR N/A
- NODK N/A
- EPS
- ATYR N/A
- NODK N/A
- Revenue
- ATYR N/A
- NODK $322,139,000.00
- Revenue This Year
- ATYR $960.85
- NODK N/A
- Revenue Next Year
- ATYR $1,283.47
- NODK N/A
- P/E Ratio
- ATYR N/A
- NODK $43.66
- Revenue Growth
- ATYR N/A
- NODK 3.15
- 52 Week Low
- ATYR $1.48
- NODK $12.01
- 52 Week High
- ATYR $5.98
- NODK $17.24
- Technical
- Relative Strength Index (RSI)
- ATYR 55.98
- NODK 48.41
- Support Level
- ATYR $4.78
- NODK $12.42
- Resistance Level
- ATYR $5.50
- NODK $12.95
- Average True Range (ATR)
- ATYR 0.37
- NODK 0.48
- MACD
- ATYR -0.09
- NODK 0.03
- Stochastic Oscillator
- ATYR 36.12
- NODK 49.60
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About NODK NI Holdings Inc.
NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.